http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1937273-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_132aa5ddba376cda52c2bedb26765245
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-585
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
filingDate 2006-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b83b5929fadb30ada61df1f7fdf72324
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_810e166703c04ec2667bf20d90104fc3
publicationDate 2008-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1937273-A1
titleOfInvention Method for manufacturing a monophasic pharmaceutical product for oral therapy of dysfunctional uterine bleeding
abstract The invention relates to a method for manufacturing a monophasic pharmaceutical product for oral therapy of dysfunctional uterine bleeding, where an oral monophasic combination of dienogest and ethinylestradiol in low dosage is used together with one or more pharmaceutically acceptable excipients/carriers, with which moderate proliferation of the endometrium with complete transformation and brief and slight withdrawal bleeding in the hormone-free period is achieved through the hormone levels remaining at a constant low level.
priorityDate 2005-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127508829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128189580
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5991
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID492274
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129479675
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6230
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5832
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423123
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID492274
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID40973
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5757
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396137
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399323
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412118
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426388

Total number of triples: 36.